Stay in touch about special discounts, nutrition tips and additional education.
We understand that whole-body health and wellness is tied to the complex ecosystem of microorganisms that is the microbiome, and that addressing imbalances in the microbiome transforms people’s lives from the inside.
Our mission is simple: to improve the lives of millions through microbiome products. To that end, we are creating products that have the power and efficacy of a pharmaceutical with the safety and accessibility of a probiotic.
Colleen Cutcliffe, Ph.D., is co-founder and Chief Executive Officer of Pendulum Therapeutics. She has more than 25 years of experience leading biology teams across academia, pharmaceuticals, and biotechnology.
Prior to founding Pendulum, Colleen was Senior Manager of Biology at Pacific Biosciences and a scientist at Elan Pharmaceuticals. She completed her postdoctoral studies at Northwestern’s Children’s Memorial Hospital.
Colleen holds a Ph.D. in Biochemistry and Molecular Biology from Johns Hopkins University and a B.A. in Biochemistry from Wellesley College.
“I am excited to be at Pendulum working towards unlocking the promise of the microbiome and building products to improve the health and lives of millions of people. Leading a team of world-class experts in medicine, lab science, manufacturing, finance and commercialization who work together fantastically makes my job easy.”
John Eid, Ph.D., is co-founder and Chief Scientific Officer of Pendulum Therapeutics. He has nearly two decades of experience leading technology development across advanced microscopy, single-molecule analysis, automated data acquisition, biophysical modeling, and genome sequencing.
Prior to co-founding Pendulum, John was a principal scientist at Pacific Biosciences, where he worked at the forefront of next-generation sequencing technology. He completed his postdoctoral research at the Rowland Institute at Harvard University.
John holds a Ph.D. in Biophysics and Computational Biology from the University of Illinois Urbana-Champaign and a B.S. in Applied and Engineering Physics from Cornell University.
“It is exciting to have a front row seat on the evolution of the microbiome field from a purely academic endeavor into a field that is actually helping people in the here and now.”
Prior to co-founding Pendulum, Jim served as a senior staff scientist at Pacific Biosciences. He completed his Ph.D. in Biostatistics at the University of California, Berkeley and his B.A. in Computing & Information Systems at Northwestern University. He has a passion for experimental design, programming languages, and taking long walks with his dog.
“I feel fortunate to have worked with smart, motivated people on interesting problems. Building products that help people is incredibly motivating.”
Dr. Perlman is board-certified in Internal Medicine and specializes in both integrative and functional medicine. With more than 25 years of clinical, entrepreneurial, and leadership experience, he most recently served as the Director of Integrative Health and Wellbeing at the Mayo Clinic. Prior to that, he served as the Associate Vice President for Health and Wellness for the Duke University Health System. Dr. Perlman received his BA from Tufts University, his MD from the Boston University School of Medicine, and his MPH from the Boston University School of Public Health.
"It is critical to educate people on how a targeted approach to a healthy gut microbiome can positively affect overall health and wellbeing to help them improve vitality and live their best lives."
Colleen Cutcliffe, Ph.D., is co-founder and Chief Executive Officer of Pendulum Therapeutics. She has more than 25 years of experience leading biology teams across academia, pharmaceuticals, and biotechnology.
Prior to founding Pendulum, Colleen was Senior Manager of Biology at Pacific Biosciences and a scientist at Elan Pharmaceuticals. She completed her postdoctoral studies at Northwestern’s Children’s Memorial Hospital.
Colleen holds a Ph.D. in Biochemistry and Molecular Biology from Johns Hopkins University and a B.A. in Biochemistry from Wellesley College.
“I am excited to be at Pendulum working towards unlocking the promise of the microbiome and building products to improve the health and lives of millions of people. Leading a team of world-class experts in medicine, lab science, manufacturing, finance and commercialization who work together fantastically makes my job easy.”
John Eid, Ph.D., is co-founder and Chief Scientific Officer of Pendulum Therapeutics. He has nearly two decades of experience leading technology development across advanced microscopy, single-molecule analysis, automated data acquisition, biophysical modeling, and genome sequencing.
Prior to co-founding Pendulum, John was a principal scientist at Pacific Biosciences, where he worked at the forefront of next-generation sequencing technology. He completed his postdoctoral research at the Rowland Institute at Harvard University.
John holds a Ph.D. in Biophysics and Computational Biology from the University of Illinois Urbana-Champaign and a B.S. in Applied and Engineering Physics from Cornell University.
“It is exciting to have a front row seat on the evolution of the microbiome field from a purely academic endeavor into a field that is actually helping people in the here and now.”
Prior to co-founding Pendulum, Jim served as a senior staff scientist at Pacific Biosciences. He completed his Ph.D. in Biostatistics at the University of California, Berkeley and his B.A. in Computing & Information Systems at Northwestern University. He has a passion for experimental design, programming languages, and taking long walks with his dog.
“I feel fortunate to have worked with smart, motivated people on interesting problems. Building products that help people is incredibly motivating.”
Dr. Perlman is board-certified in Internal Medicine and specializes in both integrative and functional medicine. With more than 25 years of clinical, entrepreneurial, and leadership experience, he most recently served as the Director of Integrative Health and Wellbeing at the Mayo Clinic. Prior to that, he served as the Associate Vice President for Health and Wellness for the Duke University Health System. Dr. Perlman received his BA from Tufts University, his MD from the Boston University School of Medicine, and his MPH from the Boston University School of Public Health.
"It is critical to educate people on how a targeted approach to a healthy gut microbiome can positively affect overall health and wellbeing to help them improve vitality and live their best lives."
Inspired by our mission? We’re always on the lookout for the best and brightest to help bring innovative microbiome solutions to life.
See Open Roles
